5-MeO-DiPT hidroklorid
5-MeO-DiPT hidroklorid Cenovni razpon: od €23.50 do €336.00
Nazaj na izdelke
EPT fumarat (N-etil-N-propiltriptamin)
EPT fumarat (N-etil-N-propiltriptamin) Cenovni razpon: od €23.50 do €336.00
5-MeO-DMT freebase - slika 1
5-MeO-DMT freebase - slika 2

5-MeO-DMT prosta baza

Lastnosti proste baze 5-MeO-DMT

Sinonim: 5-metoksi-N,N-dimetiltriptamin
Številka CAS: 1019-45-0
Formula: 3-[2-(dimetilamino)etil]-5-metoksiindol
Molska masa: 218,3 g/mol
Čistost: >97%

Cenovni razpon: od €25.00 do €700.00

Dodaj za primerjavo
Dodaj na seznam želja
PRIHRANITE 15%

več 2 izdelkov

PRIHRANITE 50%

6 za ceno 3

* Informacije na tej strani so povzetek in niso namenjene zajemanju vseh razpoložljivih informacij o tem zdravilu. Ne zajemajo vseh možnih načinov uporabe, navodil, previdnostnih ukrepov, interakcij zdravil ali neželenih učinkov in niso nadomestilo za strokovno znanje in presojo vašega zdravstvenega delavca.

5-MeO-DMT Freebase – Scientific Product Documentation

General Description

5-MeO-DMT (5-Methoxy-N,N-dimethyltryptamine) freebase is a naturally occurring tryptamine with a potent psychoactive profile, found in various plants and animal secretions. In its freebase form, it offers superior volatility for certain research methods, making it valuable for pharmacological and neuroscience studies.

Tehnične specifikacije

ParameterSpecification
Chemical FormulaC₁₃H₁₈N₂O
Molecular Weight218,29 g/mol
Čistost≥98% (HPLC-UV analyzed)
FormCrystalline/white powder
SolubilitySoluble in organic solvents (ethanol, methanol, DMSO), limited in water
Melting point60–65 °C (prosta baza)
StabilityLight and oxygen sensitive; store under inert gas

Znanstvene aplikacije

1. Neuropharmacological Research

  • Serotonergic Action:  Potent 5-HT₁ₐ/₂ₐ agonist, relevant for studies of consciousness modulation.

  • EEG/fMRI studies:  Investigation of acute effects on brain wave patterns (e.g. gamma oscillations).

  • Neuroplasticity:  Possible BDNF-enhancing effects (in animal models).

2. Metabolic & Toxicological Studies

  • MAO-dependent metabolism:  Investigation of CYP2D6 and MAO-A degradation pathways.

  • Dose-dependent toxicity:  Determination of safety margins in cell cultures.

3. Comparative Pharmacology

  • Compared to DMT:  Higher potency but shorter duration of action (15-30 min when inhaled).

  • Compared to psilocybin:  Differences in receptor affinity and subjective effects.

Experimental Guidelines

Recommended Concentrations (In Vitro)

ApplicationConcentration rangeTopilo
Testi vezave receptorjev1 nM – 10 µMPBS/DMSO (≤0,1%)
Cell culture experiments0,1–100 µMDMEM/FBS
Gas chromatography1 mg/ml (v metanolu)Metanol (HPLC kakovosti)

Safety protocols

  • Personal Protection:  Lab coat, nitrile gloves, safety glasses, FFP2 mask when handling powder.

  • Ventilation:  Always work under a fume cupboard when heating/evaporating.

  • Storage:  In amber vials, under argon, at -20°C (long term).

Stability & Storage

  • Shelf life:

    • Room temperature: <24 hours in solution.

    • 4°C: Stable for 3 days (under argon).

    • -20°C: >6 months (unchanged purity).

  • Degradation products:

    • Oxidation to indole derivatives (check by TLC/HPLC).

Analytical Certification

Each batch includes:

  1. HPLC-UV kromatogram  (λ=280 nm, C18 column)

  2. GC-MS confirmation  (characteristic fragments: m/z 174, 160)

  3. Residual solvent analysis  (≤500 ppm)

  4. Water content  (Karl Fischer, <1%)

Legal Status (Netherlands)

  • Opium Act:  Not explicitly regulated, but possibly under analogous legislation.

  • Legislation:  A licence is required for scientific institutions (Appendix 2, Opium Act).

  • Export restrictions:  CITES listing (due to natural sources such as  Incilius alvarius ).

Pogosto zastavljena vprašanja (FAQ)

Q1: What is the difference between freebase and fumaric acid salt?
A: Freebase is more volatile (suitable for evaporation experiments), while fumaric acid salt is more stable in solutions.

Q2: How is 5-MeO-DFT detected in toxicology screens?
A: Identifiable by:

  • LC-MS/MS (predhodni ion m/z 219 → produktni ion m/z 174)

  • Immunoassays: Cross-reactivity with some DMT tests (≤30%).

Q3: Are there any known pharmacokinetic interactions?
O:  Dangerous combinations:

  • MAO inhibitors (risk of serotonin syndrome).

  • SSRIs (reduced efficacy due to competition).

Q4: How to dispose of waste?
A: Inactivate with:

  1. Dilute hydrochloric acid (0.1M) for neutralization.

  2. Absorption with activated carbon.

  3. Dispose of as  hazardous chemical waste  (UN number: 3249).

References & Contact

Key publications:

  • Szára, S. (2007). "DMT in 5-MeO-DMT: zgodnje študije na ljudeh".

  • Uthaug et al. (2021). Psihofarmakologija 5-MeO-DMT.

This product is intended solely for legitimate scientific research. Not for human or veterinary use. Users must comply with all local regulations.